Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genmab AS

www.genmab.com

Latest From Genmab AS

Seattle Genetics Win Early US FDA Approval For Tukysa, Plans Rapid Launch

Tucatinib, approved for advanced unresectable or metastatic HER2-positive breast cancer, has a list price of $18,500 per month or $111,000 for a full course. Doctors can order the drug immediately.

Approvals Cancer

2019 IPOs: Startup Firms Saw Nearly One-Third Of Total Proceeds

Last year, a total of 67 biopharma and medtech companies completed initial public offerings (IPOs), raising for $8.55bn between them.

Commercial Companies

Sanofi’s Sarclisa Gets EMA Backing In Myeloma, Mirroring FDA OK

The EMA has recommended Sanofi’s anti-CD38 antibody Sarclisa as a combination-based third-line treatment for multiple myeloma, after US approval earlier in March.

Companies Cancer

Immatics To Go Public Through Merger With ‘Blank Check’ Company Arya

German TCR developer in partnerships with GSK and BMS will go public and receive $252m at closing in a reverse merger-type transaction with Arya.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Genmab AS
  • Senior Management
  • Jan van de Winkel, PhD, Pres. & CEO
    David A Eatwell, EVP, CFO
    Judith Klimovsky, MD, EVP, Chief Dev. Officer
  • Contact Info
  • Genmab AS
    Phone: (45) 7020 2728
    Kalvebod Brygge 43
    Copenhagen, 1560 V
    Denmark
UsernamePublicRestriction

Register